双相抑郁脑网络连接组特征及基于连接组的疗效预测模型
该研究对580例双相抑郁患者和116名健康对照的静息态功能MRI进行连接组分析,发现患者存在特定脑网络内及网络间功能连接异常和全局拓扑改变。基于治疗前脑连接组的支持向量回归模型可预测喹硫平4周疗效,并在独立队列中验证了预测潜力。
要点
- 双相抑郁患者默认模式网络、感觉运动网络和皮层下网络内连接升高,皮层下网络与皮层网络间连接降低。
- 患者全局效率降低、特征路径长度增加。
- 治疗前脑连接组可预测喹硫平疗效,预测与实测HAMD减分率相关r=0.4493。
核心结论
- 双相抑郁存在特征性脑网络连接组异常模式。
- 基于治疗前脑连接组的机器学习模型可预测喹硫平治疗反应,识别出的连接网络可能作为未来精准治疗的功能靶点。
研究设计与样本
- 对580例双相抑郁患者和116名健康对照的静息态功能MRI数据进行连接组分析。
- 其中148例患者接受4周喹硫平治疗并有治疗后临床评估。
- 采用机器学习构建基于治疗前脑连接组的预测模型,并在独立队列(n=43)中验证。
主要发现
- 与健康对照相比,双相抑郁患者默认模式网络、感觉运动网络和皮层下网络内功能连接升高。
- 网络间功能连接表现为默认模式网络、感觉运动网络与额顶网络、腹侧注意网络之间连接增加,皮层下网络与皮层网络(尤其默认模式网络和额顶网络)之间连接降低。
- 全局网络拓扑分析显示双相抑郁患者全局效率降低、特征路径长度增加。
- 支持向量回归模型预测喹硫平疗效,预测与实测HAMD减分率高度对应(r(df=147)=0.4493,p=2*10-4)。
- 疗效特异性网络主要涵盖感觉运动网络与皮层下网络之间以及额顶网络、默认模式网络与腹侧注意网络之间的功能连接,在独立队列(n=43)中预测治疗反应r=0.3940。
关键数值与推荐
- 预测模型与实测HAMD减分率的相关系数r(df=147)=0.4493,p=2*10-4。
- 独立验证队列(n=43)中预测治疗反应的r=0.3940。
临床怎么用
- 治疗前静息态功能连接组特征有望辅助预测双相抑郁患者对喹硫平的治疗反应。
- 识别的感觉运动网络-皮层下网络及额顶网络-默认模式网络-腹侧注意网络连接可能作为精准治疗的功能靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Aberrant functional connectivity (FC) between brain networks has been indicated closely associated with bipolar disorder (BD). However, the previous findings of specific brain network connectivity patterns have been inconsistent, and the clinical utility of FCs for predicting treatment outcomes in bipolar depression was underexplored. To identify robust neuro-biomarkers of bipolar depression, a connectome-based analysis was conducted on resting-state functional MRI (rs-fMRI) data of 580 bipolar depression patients and 116 healthy controls (HCs). A subsample of 148 patients underwent a 4-week quetiapine treatment with post-treatment clinical assessment. Adopting machine learning, a predictive model based on pre-treatment brain connectome was then constructed to predict treatment response and identify the efficacy-specific networks. Distinct brain network connectivity patterns were observed in bipolar depression compared to HCs. Elevated intra-network connectivity was identified within the default mode network (DMN), sensorimotor network (SMN), and subcortical network (SC); and as to the inter-network connectivity, increased FCs were between the DMN, SMN and frontoparietal (FPN), ventral attention network (VAN), and decreased FCs were between the SC and cortical networks, especially the DMN and FPN. And the global network topology analyses revealed decreased global efficiency and increased characteristic path length in BD compared to HC. Further, the support vector regression model successfully predicted the efficacy of quetiapine treatment, as indicated by a high correspondence between predicted and actual HAMD reduction ratio values (r(df=147)=0.4493, p = 2*10-4). The identified efficacy-specific networks primarily encompassed FCs between the SMN and SC, and between the FPN, DMN, and VAN. These identified networks further predicted treatment response with r = 0.3940 in the subsequent validation with an independent cohort (n = 43). These findings presented the characteristic aberrant patterns of brain network connectome in bipolar depression and demonstrated the predictive potential of pre-treatment network connectome for quetiapine response. Promisingly, the identified connectivity networks may serve as functional targets for future precise treatments for bipolar depression.
引用
- Xi C, Lu B, Guo X, et al. Characteristics of brain network connectome and connectome-based efficacy predictive model in bipolar depression. Mol Psychiatry. 2025. PMID: 40615558. doi:10.1038/s41380-025-03099-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。